Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan/Amlodipine FDC vs Monotherapy in Severe Hypertension
NCT00860262Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of telmisartan, amlodipine in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Mar 2009; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00860262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00860262.